Axonyx Announces Membership Changes to Its Board of Directors.Business Editors NEW YORK--(BUSINESS WIRE)--Jan. 8, 2003 AXONYX INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AXYX) announced today that Steven H. Ferris, Ph.D., has joined the Company's Board of Directors. Dr. Ferris is a neuropsychologist Neuropsychologist A clinical psychologist who specializes in assessing psychological status caused by a brain disorder. Mentioned in: Post-Concussion Syndrome , psychopharmacologist and gerontologist who has been studying brain aging and Alzheimer's disease for almost thirty years. Dr. Ferris is the Friedman Professor of the Alzheimer's Disease Center in the Department of Psychiatry at New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the (NYU NYU New York University NYU New York Undercover (TV show) ) School of Medicine, Executive Director of NYU's Silberstein Institute for Aging and Dementia and Principal Investigator of their NIA-supported Alzheimer's Disease Center. Dr. Ferris has served as the Associate Editor in Chief of Alzheimer's Disease and Associated Disorders, is a member of the Medical and Scientific Affairs Council of the National Alzheimer's Association, has served on several NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. peer review panels, and has been a member of the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Advisory Committee which reviews new drugs for Alzheimer's disease. The Company also announced that Mr. Christopher Wetherhill is leaving the Board of Directors. Mr. Wetherhill has been a member of the Board of Directors of the Company since August 1997. "Dr. Ferris's broad clinical and regulatory expertise is a valuable addition to Axonyx as we progress our drugs, in particular Phenserine, through clinical development," stated Marvin S. Hausman, MD, President and Chief Executive Officer of Axonyx. "I also want to thank Mr. Christopher Wetherhill for the dedication, loyalty, and experience that he has provided the Company. I speak on behalf of all members of the Company when I wish him well in all his future endeavors." About Axonyx Axonyx Inc. is a U.S.-based biopharmaceutical company engaged in the acquisition and development of proprietary pharmaceutical compounds and new technologies useful in the diagnosis and treatment of Alzheimer's disease, human memory disorders and prion-based illnesses such as Mad Cow Disease mad cow disease: see prion. mad cow disease or bovine spongiform encephalopathy (BSE) Fatal neurodegenerative disease of cattle. Symptoms include behavioral changes (e.g. . This press release may contain forward-looking statements or predictions. These statements represent our judgment as of this date and are subject to risks and uncertainties that could materially affect the Company, including those risks and uncertainties described in the documents Axonyx files from time to time with the Securities and Exchange Commission, specifically Axonyx's Annual Report on Form 10-K. Axonyx undertakes no obligation to publicly release the result of any revisions to such forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion